twiist AID System

About Sequel Med Tech

Sequel Med Tech is a private, commercial-stage medical device company pioneering a novel automated insulin delivery (AID) system called twiist. The system differentiates itself through direct volume measurement of insulin, pharmacy channel distribution for affordability, and utilization of the Tidepool algorithm. Co-founded by renowned inventor Dean Kamen and other healthcare veterans, Sequel aims to address the significant unmet need in the diabetes market, where a majority of insulin-requiring patients are not yet using AID technology.

Therapeutic Areas